Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Effectiveness of Bisacodyl Suppository Agent for Dose Reduction of Low Dose PEG
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2019-02-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 168
- Registration Number
- NCT03849196
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Intra-parotid Facial Nerve Imaging in Parotidectomy
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2023-11-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 270
- Registration Number
- NCT03822728
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT03822520
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Structured Education Based on New Glucose Management Devices in Patients With Type 1 Diabetes Mellitus
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2019-01-07
- Last Posted Date
- 2019-03-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT03794934
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Multicenter Registry for Angiography-Derived Quantitative Flow Ratio
- First Posted Date
- 2019-01-03
- Last Posted Date
- 2024-04-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 524
- Registration Number
- NCT03791788
- Locations
- 🇰🇷
Inje University Ilsan Paik Hospital, Goyang-si, Korea, Republic of
🇰🇷Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of
🇰🇷Samsung Medical Center, Seoul, Korea, Republic of
Cell Free DNA for the Diagnosis and Treatment in Early NSCLC
Recruiting
- Conditions
- First Posted Date
- 2019-01-02
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 700
- Registration Number
- NCT03791034
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Bare Metal Stents and Drug Eluting Stents in Patients Who Underwent Blood Transfusion
Completed
- Conditions
- First Posted Date
- 2018-12-27
- Last Posted Date
- 2018-12-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 28322
- Registration Number
- NCT03788148
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gang nam-Gu, Ilwon-Dong, Korea, Republic of
The Compliance of DAPT and Statins on Clinical Outcomes in Percutaneous Coronary Intervention Patients
- First Posted Date
- 2018-12-24
- Last Posted Date
- 2018-12-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 47291
- Registration Number
- NCT03785509
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gang nam-Gu, Ilwon-Dong, Korea, Republic of
The Effects of Anesthetics on Persistent Pain Following Breast Cancer Surgery
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-12-20
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 89
- Registration Number
- NCT03782896
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-gu, Korea, Republic of
This Study is a Phase II Study of AZD6738 in Combination With Durvalumab in Patients With Solid Tumor (Cohort A (N=30): GC Who Have Failed Secondary Chemotherapy Treatments Regimen; Cohort B (B=30): Melanoma Patients Who Have Failed to IO)
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 61
- Registration Number
- NCT03780608
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath